Table 3 Baseline Characteristics of COVID-19 patients with different levels of HDL-C
|  | Low HDL-C (n = 46) | High HDL-C (n = 182) | P value |
|---|---|---|---|
Sex (male/female) | 32/14 | 83/99 | 0.004 |
Age, median (IQR), y | 46.0 (37.8, 59.0) | 45.0 (35.0, 61.0) | 0.795 |
Comorbidity | |||
 Hypertension (n, %) | 9 (19.57) | 27 (14.84) | 0.432 |
 Cardiovascular disease (n, %) | 1 (2.17) | 8 (4.40) | 0.789 |
 Diabetes (n, %) | 5 (10.87) | 10 (5.49) | 0.327 |
  Chronic liver disease (n, %) | 5 (10.87) | 7 (3.85) | 0.124 |
Symptoms | |||
 Fever (n, %) | 38 (82.61) | 135 (74.18) | 0.232 |
 Pharyngalgia (n, %) | 5 (10.87) | 29 (15.93) | 0.389 |
 Cough (n, %) | 41 (89.13) | 146 (80.22) | 0.160 |
 Expectoration (n, %) | 24 (52.17) | 81 (44.51) | 0.351 |
 Dyspnea (n, %) | 20 (43.48) | 60 (32.97) | 0.182 |
   Hemoptysis (n, %) | 3 (6.52) | 4 (2.20) | 0.298 |
 Chills (n, %) | 5 (10.87) | 24 (13.19) | 0.673 |
 Myalgia (n, %) | 6 (13.04) | 18 (9.89) | 0.724 |
 Fatigue (n, %) | 24 (52.17) | 82 (45.05) | 0.387 |
 Dizziness (n, %) | 3 (6.52) | 26 (14.29) | 0.158 |
 Headache (n, %) | 1 (2.17) | 30 (16.48) | 0.011 |
 Diarrhea (n, %) | 11 (23.91) | 41 (22.53) | 0.841 |
 Nausea (n, %) | 2 (4.35) | 28 (15.38) | 0.048 |
 Anorexia (n, %) | 26 (56.52) | 88 (48.35) | 0.322 |
 Vomiting (n, %) | 4 (8.70) | 21 (11.54) | 0.581 |
 Abdominal pain (n, %) | 1 (2.17) | 6 (3.30) | 1.000 |
Chest CT positive rate (n, %) | 46 (100.0) | 172 (94.51) | 0.221 |
Chest CT with ground-glass change (n, %) | 20 (43.48) | 88 (48.35) | 0.554 |
Severe cases (n, %) | 17 (36.96) | 27 (14.84) | 0.001 |
Length of hospital stay, median (IQR), days | 13.0 (11.0, 22.5) | 16.0 (11.0, 25.0) | 0.712 |
Virus shedding duration, median (IQR), days | 17.0 (13.5, 24.0) | 18.0 (13.0, 26.0) | 0.269 |
Mortality (n, %) | 1 (2.17) | 1 (0.55) | 0.364 |